These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30972661)

  • 1. The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events.
    Elias E; Targownik LE
    Drugs; 2019 May; 79(7):715-731. PubMed ID: 30972661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.
    Kanno T; Moayyedi P
    Curr Gastroenterol Rep; 2019 Dec; 21(12):65. PubMed ID: 31807948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinician's Guide to Proton-Pump Inhibitor Discontinuation.
    Wiens E; Kovaltchouk U; Koomson A; Targownik LE
    J Clin Gastroenterol; 2019 Sep; 53(8):553-559. PubMed ID: 31356559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors, adverse events and increased risk of mortality.
    Lanas-Gimeno A; Hijos G; Lanas Á
    Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
    [No Abstract]   [Full Text] [Related]  

  • 6. The risks of PPI therapy.
    Moayyedi P; Leontiadis GI
    Nat Rev Gastroenterol Hepatol; 2012 Feb; 9(3):132-9. PubMed ID: 22330810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications and safety of proton pump inhibitor drug use in patients with cancer.
    Triadafilopoulos G; Roorda AK; Akiyama J
    Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Bowel Bacterial Overgrowth Associated with Persistence of Abdominal Symptoms in Children Treated with a Proton Pump Inhibitor.
    Sieczkowska A; Landowski P; Zagozdzon P; Kaminska B; Lifschitz C
    J Pediatr; 2015 May; 166(5):1310-1312.e1. PubMed ID: 25681195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
    Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
    de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
    Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of long-term PPI therapy.
    Reimer C
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):443-54. PubMed ID: 23998981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies.
    Wu X; Zhang D; Yu Y; Lou L; Li X
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32406491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.
    Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT
    Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of Proton Pump Inhibitor Therapy.
    Vaezi MF; Yang YX; Howden CW
    Gastroenterology; 2017 Jul; 153(1):35-48. PubMed ID: 28528705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate proton pump inhibitor use among older adults: a retrospective chart review.
    George CJ; Korc B; Ross JS
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):249-54. PubMed ID: 19161927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.
    Ratuapli SK; Ellington TG; O'Neill MT; Umar SB; Harris LA; Foxx-Orenstein AE; Burdick GE; Dibaise JK; Lacy BE; Crowell MD
    Am J Gastroenterol; 2012 May; 107(5):730-5. PubMed ID: 22334250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of drugs used in acid-related disorders and functional gastrointestinal disorders.
    Parikh N; Howden CW
    Gastroenterol Clin North Am; 2010 Sep; 39(3):529-42. PubMed ID: 20951916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits.
    Lué A; Lanas A
    World J Gastroenterol; 2016 Dec; 22(48):10477-10481. PubMed ID: 28082800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.